TXG
10x Genomics, Inc.
Company overview
- Market capitalization
- $11.53B
- Employees
- 1,178
- Latest publication
- 2026-09-29
About 10x Genomics, Inc.
10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific. The company offers Chromium platform, a single cell portfolio that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; and QuantumScale single cell RNA and single cell methylation kits. It also provides Visium platform, a spatial analysis platform that uses high density DNA arrays to encode the physical location of biological analytes within a sample. This platform includes HD WT panel gene expression, and HD 3' gene expression assays, as well as the Visium CytAssist, an instrument designed to simplify and optimize the Visium solution workflow by facilitating the transfer of transcriptomic analytes from standard glass slides to Visium slides. In addition, the company offers Xenium Analyzer instrument enables researchers to detect and preserve the cellular location of hundreds of RNA targets directly in a fresh frozen or FFPE tissue section without the need for conventional sequencing; and slides and reagents. Further, it provides various software products comprising Cell Ranger, a scRNA-seq processing pipeline in scientific literature; Loupe Browser, which enables intuitive single-cell, spatial, and multiomic data visualization; and Xenium Explorer that enables intuitive in situ data visualization, which allows researchers to explore subcellular gene expression, spatial organization, and tissue-scale patterns. The company serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q2 20252025-06-30 · USD | Q3 20182018-09-30 · USD |
|---|---|---|---|
| Total Revenue | 151,036,000USD | 172,908,000USD | 36,607,000USD |
| Cost Of Revenue | 38,539,000USD | 47,824,000USD | 5,241,000USD |
| Gross Profit | 112,497,000USD | 125,084,000USD | 31,366,000USD |
| Research Development | 56,791,000USD | 61,224,000USD | 11,085,000USD |
| Selling General Administrative | 78,661,000USD | 74,434,000USD | 19,110,000USD |
| Total Operating Expenses | 132,052,000USD | 94,958,000USD | 30,195,000USD |
| Operating Income | -19,555,000USD | 30,126,000USD | -14,933,000USD |
| Total Other Income Expense Net | 910,000USD | 6,871,000USD | -16,500,000USD |
| Interest Income | 4,797,000USD | 4,271,000USD | — |
| Interest Expense | 0USD | 3,000USD | 659,000USD |
| Income Before Tax | -18,645,000USD | 36,997,000USD | -15,329,000USD |
| Income Tax Expense | -714,000USD | 2,459,000USD | 16,000USD |
| Net Income | -17,931,000USD | 34,538,000USD | -15,345,000USD |
| Unclassified Operating Expenses | — | -40,700,000USD | — |
| Net Interest Income | — | 4,268,000USD | — |
| Tax Provision | — | 2,459,000USD | — |
| Net Income From Continuing Ops | — | 34,538,000USD | -15,345,000USD |
| Ebit | — | 37,000,000USD | -15,518,000USD |
| Ebitda | — | 46,651,000USD | -14,670,000USD |
| Depreciation And Amortization | — | 9,651,000USD | 848,000USD |
| Reconciled Depreciation | — | 9,651,000USD | 848,000USD |
| Non Operating Income Net Other | — | — | 0USD |
| Minority Interest | — | — | 0USD |
| Discontinued Operations | — | — | 0USD |
| Net Income Applicable To Common Shares | — | — | -15,345,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 1,030,066,000USD | 1,015,759,000USD | 1,041,365,000USD | 1,027,361,000USD | 979,970,000USD | 903,393,000USD | 918,636,000USD | 937,794,000USD |
| Total Current Assets | 674,671,000USD | 669,733,000USD | 684,451,000USD | 659,827,000USD | 655,661,000USD | 579,730,000USD | 584,387,000USD | 593,893,000USD |
| Other Current Assets | 19,393,000USD | 20,261,000USD | 22,208,000USD | 19,195,000USD | 20,365,000USD | 25,566,000USD | 20,016,000USD | 18,159,000USD |
| Other Non Current Assets | 15,308,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 204,520,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 118,509,000USD | 113,598,000USD | 153,454,000USD | 147,324,000USD | 112,221,000USD | 107,900,000USD | 117,633,000USD | 121,235,000USD |
| Other Current Liabilities | 7,075,000USD | — | — | — | — | — | — | — |
| Other Non Current Liabilities | 6,556,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 825,546,000USD | 814,324,000USD | 796,326,000USD | 785,120,000USD | 773,279,000USD | 706,895,000USD | 710,134,000USD | 722,804,000USD |
| Total Equity Including Noncontrolling Interest | 825,546,000USD | — | — | — | — | — | — | — |
| Deferred Revenue | 23,610,000USD | — | — | — | — | — | — | — |
| Deferred Revenue Non Current | 9,683,000USD | — | — | — | — | — | — | — |
| Net Receivables | 47,545,000USD | 56,137,000USD | 82,493,000USD | 96,592,000USD | 119,067,000USD | 52,549,000USD | 87,862,000USD | 83,525,000USD |
| Inventory | 52,616,000USD | 53,487,000USD | 56,341,000USD | 61,956,000USD | 68,968,000USD | 74,710,000USD | 83,107,000USD | 94,050,000USD |
| Property Plant Equipment Net | 272,009,000USD | 278,981,000USD | 287,161,000USD | 296,184,000USD | 302,410,000USD | 301,664,000USD | 309,938,000USD | 318,338,000USD |
| Goodwill | 6,918,000USD | — | — | — | — | — | — | — |
| Intangible Assets | 61,160,000USD | 59,910,000USD | 62,329,000USD | 64,759,000USD | 14,714,000USD | 15,192,000USD | 15,671,000USD | 16,149,000USD |
| Accounts Payable | 20,694,000USD | 17,425,000USD | 12,733,000USD | 18,069,000USD | 15,938,000USD | 10,068,000USD | 12,909,000USD | 26,210,000USD |
| Short Term Debt | 12,015,000USD | 11,330,000USD | 10,985,000USD | 10,543,000USD | 9,669,000USD | 9,443,000USD | 9,286,000USD | 9,415,000USD |
| Common Stock | 2,000USD | 2,000USD | 2,000USD | 2,000USD | 2,000USD | 2,000USD | 2,000USD | 2,000USD |
| Retained Earnings | -1,541,992,000USD | -1,524,061,000USD | -1,510,591,000USD | -1,494,339,000USD | -1,466,867,000USD | -1,501,405,000USD | -1,467,047,000USD | -1,418,019,000USD |
| Accumulated Other Comprehensive Income | 77,000USD | 114,000USD | 225,000USD | 138,000USD | 220,000USD | -367,000USD | -493,000USD | 32,000USD |
| Cash And Equivalents | 502,512,000USD | — | — | — | — | — | — | — |
| Total Liab | — | 201,435,000USD | 245,039,000USD | 242,241,000USD | 206,691,000USD | 196,498,000USD | 208,502,000USD | 214,990,000USD |
| Other Current Liab | — | 60,501,000USD | 105,834,000USD | 96,573,000USD | 65,165,000USD | 62,665,000USD | 69,844,000USD | 63,559,000USD |
| Capital Stock | — | 2,000USD | 2,000USD | 2,000USD | 2,000USD | 2,000USD | 2,000USD | 2,000USD |
| Good Will | — | 4,511,000USD | 4,511,000USD | 4,511,000USD | 4,511,000USD | 4,511,000USD | 4,511,000USD | 4,511,000USD |
| Cash | — | 490,285,000USD | 473,966,000USD | 432,508,000USD | 397,712,000USD | 377,061,000USD | 344,067,000USD | 398,159,000USD |
| Cash And Short Term Investments | — | 539,848,000USD | 523,409,000USD | 482,084,000USD | 447,261,000USD | 426,905,000USD | 393,402,000USD | 398,159,000USD |
| Current Deferred Revenue | — | 24,342,000USD | 23,902,000USD | 22,139,000USD | 21,449,000USD | 20,949,000USD | 20,658,000USD | 17,760,000USD |
| Net Debt | — | -408,896,000USD | -316,229,000USD | -269,081,000USD | -310,968,000USD | -296,987,000USD | -261,454,000USD | -312,283,000USD |
| Short Long Term Debt Total | — | 81,389,000USD | 157,737,000USD | 163,427,000USD | 86,744,000USD | 80,074,000USD | 82,613,000USD | 85,876,000USD |
| Short Term Investments | — | 49,563,000USD | 49,443,000USD | 49,576,000USD | 49,549,000USD | 49,844,000USD | 49,335,000USD | 0USD |
| Property Plant Equipment Gross | — | 439,926,000USD | 440,625,000USD | 441,993,000USD | 442,200,000USD | 432,777,000USD | 432,905,000USD | 442,965,000USD |
| Common Stock Shares Outstanding | — | 128,291,153shares | 127,078,342shares | 125,502,291shares | 124,509,720shares | 122,606,091shares | 121,596,351shares | 120,733,030shares |
| Non Current Assets Total | — | 346,026,000USD | 356,914,000USD | 367,534,000USD | 324,309,000USD | 323,663,000USD | 334,249,000USD | 343,901,000USD |
| Non Current Liabilities Total | — | 87,837,000USD | 91,585,000USD | 94,917,000USD | 94,470,000USD | 88,598,000USD | 90,869,000USD | 93,755,000USD |
| Non Current Liabilities Other | — | 7,640,000USD | 7,708,000USD | 7,604,000USD | 6,125,000USD | 5,398,000USD | 5,029,000USD | 4,945,000USD |
| Non Currrent Assets Other | — | 2,624,000USD | 2,913,000USD | 1,879,000USD | 2,674,000USD | 2,296,000USD | 4,129,000USD | 4,903,000USD |
| Net Working Capital | — | 556,135,000USD | 530,997,000USD | 512,503,000USD | 543,440,000USD | 471,830,000USD | 466,754,000USD | 472,658,000USD |
| Unclassified Non Current Liabilities | — | 80,197,000USD | 83,877,000USD | 87,313,000USD | 88,345,000USD | 83,200,000USD | 85,840,000USD | 88,810,000USD |
| Unclassified Equity | — | 2,338,267,000USD | 2,306,688,000USD | 2,279,317,000USD | 2,239,922,000USD | 2,208,663,000USD | 2,177,670,000USD | 2,140,787,000USD |
| Unclassified Current Liabilities | — | — | — | — | — | 4,775,000USD | 4,936,000USD | 4,291,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 1,041,365,000USD | 918,636,000USD | 965,143,000USD | 1,028,980,000USD | 1,018,826,000USD | 929,341,000USD | 605,923,000USD | 124,310,000USD |
| Intangible Assets | 62,329,000USD | 15,671,000USD | 16,616,000USD | 22,858,000USD | 25,397,000USD | 22,354,000USD | 400,000USD | 400,000USD |
| Other Current Assets | 22,208,000USD | 20,016,000USD | 18,789,000USD | 19,211,000USD | 14,924,000USD | 29,596,000USD | 8,033,000USD | 4,498,000USD |
| Total Liab | 245,039,000USD | 208,502,000USD | 224,100,000USD | 223,237,000USD | 201,258,000USD | 190,269,000USD | 185,840,000USD | 344,297,000USD |
| Total Stockholder Equity | 796,326,000USD | 710,134,000USD | 741,043,000USD | 805,743,000USD | 817,568,000USD | 739,072,000USD | 420,083,000USD | -219,987,000USD |
| Other Current Liab | 105,834,000USD | 69,844,000USD | 81,704,000USD | 88,375,000USD | 77,913,000USD | 92,633,000USD | 36,842,000USD | 16,250,000USD |
| Common Stock | 2,000USD | 2,000USD | 2,000USD | 2,000USD | 2,000USD | 2,000USD | 2,000USD | 1,000USD |
| Capital Stock | 2,000USD | 2,000USD | 2,000USD | 2,000USD | 2,000USD | 2,000USD | 2,000USD | 1,000USD |
| Retained Earnings | -1,510,591,000USD | -1,467,047,000USD | -1,284,420,000USD | -1,029,321,000USD | -863,321,000USD | -805,098,000USD | -262,367,000USD | -231,116,000USD |
| Good Will | 4,511,000USD | 4,511,000USD | 4,511,000USD | 4,511,000USD | 4,511,000USD | 0USD | — | 0USD |
| Cash | 473,966,000USD | 344,067,000USD | 359,284,000USD | 219,746,000USD | 587,447,000USD | 663,603,000USD | 424,166,000USD | 65,080,000USD |
| Cash And Short Term Investments | 523,409,000USD | 393,402,000USD | 388,695,000USD | 429,984,000USD | 587,447,000USD | 663,603,000USD | 424,166,000USD | 65,080,000USD |
| Total Current Assets | 684,451,000USD | 584,387,000USD | 596,022,000USD | 635,035,000USD | 747,591,000USD | 774,366,000USD | 480,840,000USD | 106,236,000USD |
| Total Current Liabilities | 153,454,000USD | 117,633,000USD | 127,162,000USD | 130,957,000USD | 110,357,000USD | 118,126,000USD | 63,049,000USD | 32,362,000USD |
| Current Deferred Revenue | 23,902,000USD | 20,658,000USD | 13,150,000USD | 7,867,000USD | 5,340,000USD | 6,199,000USD | 3,297,000USD | 2,776,000USD |
| Net Debt | -316,229,000USD | -261,454,000USD | -263,914,000USD | -124,570,000USD | -505,469,000USD | -600,625,000USD | -394,447,000USD | -35,404,000USD |
| Short Term Debt | 10,985,000USD | 9,286,000USD | 11,521,000USD | 9,037,000USD | 5,131,000USD | 5,936,000USD | 9,882,000USD | 4,187,000USD |
| Short Long Term Debt Total | 157,737,000USD | 82,613,000USD | 95,370,000USD | 95,176,000USD | 81,978,000USD | 62,978,000USD | 29,719,000USD | 29,676,000USD |
| Short Term Investments | 49,443,000USD | 49,335,000USD | 29,411,000USD | 210,238,000USD | 0USD | — | — | 0USD |
| Net Receivables | 82,493,000USD | 87,862,000USD | 114,832,000USD | 104,211,000USD | 85,254,000USD | 51,208,000USD | 33,371,000USD | 28,088,000USD |
| Inventory | 56,341,000USD | 83,107,000USD | 73,706,000USD | 81,629,000USD | 59,966,000USD | 29,959,000USD | 15,270,000USD | 8,570,000USD |
| Accounts Payable | 12,733,000USD | 12,909,000USD | 15,738,000USD | 21,599,000USD | 17,351,000USD | 4,709,000USD | 13,028,000USD | 8,792,000USD |
| Property Plant Equipment Net | 287,161,000USD | 309,938,000USD | 344,932,000USD | 359,210,000USD | 230,410,000USD | 119,823,000USD | 48,821,000USD | 11,127,000USD |
| Property Plant Equipment Gross | 440,625,000USD | 432,905,000USD | 448,423,000USD | 359,210,000USD | 230,410,000USD | 72,840,000USD | 48,821,000USD | 11,127,000USD |
| Accumulated Other Comprehensive Income | 225,000USD | -493,000USD | -429,000USD | -4,335,000USD | 22,000USD | -50,000USD | -46,000USD | -37,000USD |
| Common Stock Shares Outstanding | 124,749,885shares | 120,451,550shares | 117,165,036shares | 113,858,684shares | 110,347,937shares | 101,151,675shares | 78,182,732shares | 13,392,273shares |
| Non Current Assets Total | 356,914,000USD | 334,249,000USD | 369,121,000USD | 393,945,000USD | 271,235,000USD | 154,975,000USD | 125,083,000USD | 18,074,000USD |
| Non Current Liabilities Total | 91,585,000USD | 90,869,000USD | 96,938,000USD | 92,280,000USD | 90,901,000USD | 72,143,000USD | 122,791,000USD | 311,935,000USD |
| Non Current Liabilities Other | 7,708,000USD | 5,029,000USD | 4,275,000USD | 6,141,000USD | 90,901,000USD | 72,143,000USD | 1,091,000USD | 771,000USD |
| Non Currrent Assets Other | 2,913,000USD | 4,129,000USD | 3,062,000USD | 7,366,000USD | 3,319,000USD | 12,798,000USD | 76,262,000USD | 1,939,000USD |
| Net Working Capital | 530,997,000USD | 466,754,000USD | 468,860,000USD | 504,078,000USD | 637,234,000USD | 656,240,000USD | 417,791,000USD | 73,874,000USD |
| Unclassified Non Current Liabilities | 83,877,000USD | 85,840,000USD | 92,663,000USD | 79,998,000USD | -14,054,000USD | -15,101,000USD | — | 242,473,000USD |
| Unclassified Equity | 2,306,688,000USD | 2,177,670,000USD | 2,025,888,000USD | 1,839,395,000USD | 1,680,863,000USD | 1,544,216,000USD | 682,492,000USD | 11,164,000USD |
| Unclassified Current Liabilities | — | 4,936,000USD | 5,049,000USD | 4,079,000USD | 4,622,000USD | 8,649,000USD | -9,882,000USD | -3,830,000USD |
| Other Liab | — | — | — | 6,141,000USD | 14,054,000USD | 15,101,000USD | 102,954,000USD | 43,202,000USD |
| Other Assets | — | — | — | 7,366,000USD | 10,917,000USD | 82,135,000USD | 53,896,000USD | 6,947,000USD |
| Net Tangible Assets | — | — | — | 778,374,000USD | 787,660,000USD | 739,072,000USD | 397,717,000USD | -219,987,000USD |
| Unclassified Non Current Assets | — | — | — | -7,366,000USD | -3,319,000USD | -82,135,000USD | -54,296,000USD | -2,339,000USD |
| Short Long Term Debt | — | — | — | — | — | — | 9,882,000USD | 4,187,000USD |
| Long Term Debt | — | — | — | — | — | — | 19,837,000USD | 25,489,000USD |
| Deferred Long Term Liab | — | — | — | — | — | — | — | 0USD |
| Long Term Investments | — | — | — | — | — | — | — | 0USD |
| Accumulated Depreciation | — | — | — | — | — | — | — | 0USD |
| Additional Paid In Capital | — | — | — | — | — | — | — | 0USD |
| Treasury Stock | — | — | — | — | — | — | — | 0USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 19,621,000USD |
| Stock Based Compensation | 48,258,000USD |
| Deferred Income Tax | -1,434,000USD |
| Change To Account Receivables | -534,000USD |
| Change To Inventory | 5,703,000USD |
| Change To Liabilities | 8,162,000USD |
| Change In Working Capital | -14,873,000USD |
| Operating Cash Flow | 43,094,000USD |
| Capital Expenditures | -3,185,000USD |
| Net Investments | 740,000USD |
| Other Investing Activities | -6,101,000USD |
| Unclassified Investing Cash Flow | -500,000USD |
| Investing Cash Flow | -9,046,000USD |
| Common Stock Issuance | 3,289,000USD |
| Unclassified Financing Cash Flow | -8,690,000USD |
| Financing Cash Flow | -5,401,000USD |
| Effect Of Forex Changes On Cash | -101,000USD |
| Change In Cash | 28,546,000USD |
| End Cash Flow | 502,512,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -13,470,000USD | -16,252,000USD | -27,472,000USD | 34,538,000USD | -34,358,000USD | -49,028,000USD | -35,753,000USD | -37,897,000USD |
| Depreciation | 11,910,000USD | 12,100,000USD | 12,251,000USD | 9,651,000USD | 9,814,000USD | 10,564,000USD | 10,750,000USD | 10,900,000USD |
| Stock Based Compensation | 22,642,000USD | 25,219,000USD | 25,264,000USD | 27,559,000USD | 31,076,000USD | 32,540,000USD | 33,588,000USD | 38,492,000USD |
| Other Non Cash Items | -250,000USD | 1,132,000USD | 1,401,000USD | -351,000USD | -461,000USD | 552,000USD | 64,000USD | 66,000USD |
| Change To Account Receivables | 26,109,000USD | 14,102,000USD | 22,905,000USD | -65,892,000USD | 35,325,000USD | -4,370,000USD | 7,683,000USD | 122,000USD |
| Change To Inventory | 2,702,000USD | 5,582,000USD | 7,287,000USD | 7,026,000USD | 8,058,000USD | 9,619,000USD | -4,262,000USD | -5,197,000USD |
| Change In Working Capital | 5,288,000USD | 18,578,000USD | 31,770,000USD | -53,689,000USD | 28,280,000USD | -1,376,000USD | 12,992,000USD | -4,065,000USD |
| Total Cash From Operating Activities | 26,120,000USD | 40,777,000USD | 43,214,000USD | 17,708,000USD | 34,351,000USD | -6,748,000USD | 21,641,000USD | 7,496,000USD |
| Capital Expenditures | -1,597,000USD | -1,777,000USD | -687,000USD | -1,578,000USD | -1,893,000USD | -2,716,000USD | -3,889,000USD | -3,878,000USD |
| Free Cash Flow | 24,523,000USD | 39,000,000USD | 42,527,000USD | 16,130,000USD | 32,458,000USD | -9,464,000USD | 17,752,000USD | 3,618,000USD |
| Investments | 286,000USD | 624,000USD | -8,801,000USD | -939,000USD | -1,893,000USD | -51,592,000USD | -3,618,000USD | 11,947,000USD |
| Total Cashflows From Investing Activities | -1,311,000USD | -1,805,000USD | -8,801,000USD | -939,000USD | -1,893,000USD | -51,592,000USD | -3,618,000USD | 11,947,000USD |
| Total Cash From Financing Activities | -8,417,000USD | 2,242,000USD | 617,000USD | 3,522,000USD | 422,000USD | 4,517,000USD | 156,000USD | 4,603,000USD |
| Change In Cash | 16,319,000USD | 41,257,000USD | 34,997,000USD | 20,651,000USD | 32,994,000USD | -54,092,000USD | 18,335,000USD | 24,043,000USD |
| Begin Period Cash Flow | 473,966,000USD | 432,709,000USD | 397,712,000USD | 377,061,000USD | 344,067,000USD | 398,159,000USD | 379,824,000USD | 355,781,000USD |
| End Period Cash Flow | 490,285,000USD | 473,966,000USD | 432,709,000USD | 397,712,000USD | 377,061,000USD | 344,067,000USD | 398,159,000USD | 379,824,000USD |
| Other Cashflows From Financing Activities | -8,690,000USD | — | 617,000USD | 3,522,000USD | 422,000USD | 4,517,000USD | 156,000USD | 4,603,000USD |
| Other Cashflows From Investing Activities | — | -652,000USD | 502,000USD | -49,361,000USD | — | -48,876,000USD | — | -1,000,000USD |
| Unclassified Investing Cash Flow | — | — | — | 50,939,000USD | 1,893,000USD | 51,592,000USD | 3,889,000USD | 4,878,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -43,544,000USD | -182,627,000USD | -255,099,000USD | -166,000,000USD | -58,223,000USD | -542,731,000USD | -31,251,000USD | -112,485,000USD |
| Depreciation | 43,816,000USD | 43,708,000USD | 43,619,000USD | 33,006,000USD | 28,254,000USD | 19,021,000USD | 7,066,000USD | 3,905,000USD |
| Stock Based Compensation | 109,118,000USD | 140,749,000USD | 166,950,000USD | 136,848,000USD | 95,962,000USD | 48,626,000USD | 13,333,000USD | 2,658,000USD |
| Other Non Cash Items | 1,721,000USD | 3,580,000USD | 11,990,000USD | 1,957,000USD | 79,000USD | 306,017,000USD | 101,000USD | 1,247,000USD |
| Change To Account Receivables | 6,440,000USD | 26,951,000USD | -10,613,000USD | -18,948,000USD | -34,041,000USD | -17,847,000USD | -5,284,000USD | -14,747,000USD |
| Change To Inventory | 27,953,000USD | -9,777,000USD | 7,871,000USD | -21,192,000USD | -30,132,000USD | -14,601,000USD | -6,699,000USD | -3,732,000USD |
| Change In Working Capital | 24,939,000USD | 1,254,000USD | 17,343,000USD | -39,417,000USD | -87,445,000USD | -50,381,000USD | 44,764,000USD | 28,015,000USD |
| Total Cash From Operating Activities | 136,050,000USD | 6,664,000USD | -15,197,000USD | -33,606,000USD | -21,373,000USD | -217,898,000USD | 34,627,000USD | -76,409,000USD |
| Capital Expenditures | -5,935,000USD | -12,393,000USD | -49,524,000USD | -131,661,000USD | -101,278,000USD | -38,394,000USD | -42,767,000USD | -6,709,000USD |
| Free Cash Flow | 130,115,000USD | -5,729,000USD | -64,721,000USD | -165,267,000USD | -122,651,000USD | -256,292,000USD | -8,140,000USD | -83,118,000USD |
| Investments | 1,765,000USD | -32,631,000USD | 87,222,000USD | -350,887,000USD | -106,729,000USD | -38,394,000USD | -42,767,000USD | -6,709,000USD |
| Total Cashflows From Investing Activities | -13,438,000USD | -32,631,000USD | 133,492,000USD | -350,887,000USD | -106,729,000USD | -38,394,000USD | -42,767,000USD | -6,709,000USD |
| Total Cash From Financing Activities | 6,803,000USD | 10,914,000USD | 13,669,000USD | 15,817,000USD | 35,297,000USD | 468,906,000USD | 414,590,000USD | 105,367,000USD |
| Change In Cash | 129,899,000USD | -15,217,000USD | 131,931,000USD | -368,720,000USD | -92,571,000USD | 212,151,000USD | 406,405,000USD | 22,231,000USD |
| Begin Period Cash Flow | 344,067,000USD | 359,284,000USD | 227,353,000USD | 596,073,000USD | 688,644,000USD | 476,493,000USD | 70,088,000USD | 47,857,000USD |
| End Period Cash Flow | 473,966,000USD | 344,067,000USD | 359,284,000USD | 227,353,000USD | 596,073,000USD | 688,644,000USD | 476,493,000USD | 70,088,000USD |
| Other Cashflows From Investing Activities | -9,268,000USD | -1,000,000USD | -923,000USD | -215,226,000USD | -5,451,000USD | -1,728,000USD | -25,000USD | -425,000USD |
| Other Cashflows From Financing Activities | 6,803,000USD | 10,914,000USD | 13,669,000USD | 15,817,000USD | 35,297,000USD | 23,743,000USD | 3,766,000USD | 86,628,000USD |
| Unclassified Investing Cash Flow | — | 13,393,000USD | 96,717,000USD | 346,887,000USD | 106,729,000USD | 40,122,000USD | 42,792,000USD | 7,134,000USD |
| Change To Liabilities | — | — | — | 7,366,000USD | 21,843,000USD | 17,312,000USD | 5,535,000USD | 4,260,000USD |
| Net Borrowings | — | — | — | -5,409,000USD | -5,028,000USD | -37,104,000USD | -37,104,000USD | 18,739,000USD |
| Sale Purchase Of Stock | — | — | — | 21,226,000USD | 40,325,000USD | 506,010,000USD | 0USD | 0USD |
| Issuance Of Capital Stock | — | — | — | 0USD | -780,000USD | 482,267,000USD | 410,824,000USD | 86,628,000USD |
| Cash And Cash Equivalents Changes | — | — | — | -368,676,000USD | -92,805,000USD | 212,614,000USD | — | 0USD |
| Unclassified Financing Cash Flow | — | — | — | -15,817,000USD | -35,297,000USD | -23,743,000USD | 447,928,000USD | — |
| Dividends Paid | — | — | — | — | — | — | — | 0USD |
| Exchange Rate Changes | — | — | — | — | — | — | — | 0USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q2 2026Quarterly · 2026-06-30 | Geography | Americas Excluding United States | 2,917,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Geography | Asia Pacific Excluding China | 11,070,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Geography | China | 14,968,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Geography | EMEA | 39,972,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Geography | United States | 82,109,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Licensing And Royalty Revenue | 1,942,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Product And Service Revenue — Chromium Consumables | 88,451,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Product And Service Revenue — Chromium Instruments | 3,087,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Product And Service Revenue — Services | 10,681,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Product And Service Revenue — Spatial Consumables | 42,301,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Product And Service Revenue — Spatial Instruments | 4,574,000 | USD | Disclosure |
| Q1 2026Quarterly · 2026-03-31 | Geography | Americas Excluding United States | 3,406,000 | USD | 0001628280-26-032388 |
| Q1 2026Quarterly · 2026-03-31 | Geography | Asia Pacific Excluding China | 18,055,000 | USD | 0001628280-26-032388 |
| Q1 2026Quarterly · 2026-03-31 | Geography | China | 15,837,000 | USD | 0001628280-26-032388 |
| Q1 2026Quarterly · 2026-03-31 | Geography | EMEA | 36,852,000 | USD | 0001628280-26-032388 |
| Q1 2026Quarterly · 2026-03-31 | Geography | United States | 76,693,000 | USD | 0001628280-26-032388 |
| Q1 2026Quarterly · 2026-03-31 | Product | Licensing And Royalty Revenue | 947,000 | USD | 0001628280-26-032388 |
| Q1 2026Quarterly · 2026-03-31 | Product | Product And Service Revenue — Chromium Consumables | 88,894,000 | USD | 0001628280-26-032388 |
| Q1 2026Quarterly · 2026-03-31 | Product | Product And Service Revenue — Chromium Instruments | 5,223,000 | USD | 0001628280-26-032388 |
| Q1 2026Quarterly · 2026-03-31 | Product | Product And Service Revenue — Services | 8,833,000 | USD | 0001628280-26-032388 |
| Q1 2026Quarterly · 2026-03-31 | Product | Product And Service Revenue — Spatial Consumables | 40,907,000 | USD | 0001628280-26-032388 |
| Q1 2026Quarterly · 2026-03-31 | Product | Product And Service Revenue — Spatial Instruments | 6,039,000 | USD | 0001628280-26-032388 |
| Q4 2025Quarterly · 2025-12-31 | Geography | Americas Excluding United States | 3,217,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Geography | Asia Pacific Excluding China | 15,371,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Geography | China | 15,022,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Geography | EMEA | 53,463,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Geography | United States | 78,957,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-12-31 | Geography | Americas Excluding United States | 12,261,000 | USD | 0001628280-26-007822 |
| FY 2025Yearly · 2025-12-31 | Geography | Asia Pacific Excluding China | 52,070,000 | USD | 0001628280-26-007822 |
| FY 2025Yearly · 2025-12-31 | Geography | China | 70,264,000 | USD | 0001628280-26-007822 |
| FY 2025Yearly · 2025-12-31 | Geography | EMEA | 161,716,000 | USD | 0001628280-26-007822 |
| FY 2025Yearly · 2025-12-31 | Geography | United States | 346,512,000 | USD | 0001628280-26-007822 |
| FY 2025Yearly · 2025-12-31 | Product | Licensing And Royalty Revenue | 46,135,000 | USD | 0001628280-26-007822 |
| FY 2025Yearly · 2025-12-31 | Product | Product And Service Revenue — Services | 32,726,000 | USD | 0001628280-26-007822 |
| FY 2025Yearly · 2025-12-31 | Product | Product And Service Revenue — Single Cell Consumables | 363,206,000 | USD | 0001628280-26-007822 |
| FY 2025Yearly · 2025-12-31 | Product | Product And Service Revenue — Single Cell Instruments | 22,671,000 | USD | 0001628280-26-007822 |
| FY 2025Yearly · 2025-12-31 | Product | Product And Service Revenue — Spatial Consumables | 143,977,000 | USD | 0001628280-26-007822 |
| FY 2025Yearly · 2025-12-31 | Product | Product And Service Revenue — Spatial Instruments | 34,108,000 | USD | 0001628280-26-007822 |
| Q3 2025Quarterly · 2025-09-30 | Geography | Americas Excluding United States | 2,625,000 | USD | 0001628280-25-050332 |
| Q3 2025Quarterly · 2025-09-30 | Geography | Asia Pacific Excluding China | 12,318,000 | USD | 0001628280-25-050332 |
| Q3 2025Quarterly · 2025-09-30 | Geography | China | 15,189,000 | USD | 0001628280-25-050332 |
| Q3 2025Quarterly · 2025-09-30 | Geography | EMEA | 41,624,000 | USD | 0001628280-25-050332 |
| Q3 2025Quarterly · 2025-09-30 | Geography | United States | 77,246,000 | USD | 0001628280-25-050332 |
| Q3 2025Quarterly · 2025-09-30 | Product | Licensing And Royalty Revenue | 983,000 | USD | 0001628280-25-050332 |
| Q3 2025Quarterly · 2025-09-30 | Product | Product And Service Revenue — Chromium Consumables | 92,519,000 | USD | 0001628280-25-050332 |
| Q3 2025Quarterly · 2025-09-30 | Product | Product And Service Revenue — Chromium Instruments | 4,927,000 | USD | 0001628280-25-050332 |
| Q3 2025Quarterly · 2025-09-30 | Product | Product And Service Revenue — Services | 8,128,000 | USD | 0001628280-25-050332 |
| Q3 2025Quarterly · 2025-09-30 | Product | Product And Service Revenue — Spatial Consumables | 35,373,000 | USD | 0001628280-25-050332 |
| Q3 2025Quarterly · 2025-09-30 | Product | Product And Service Revenue — Spatial Instruments | 7,072,000 | USD | 0001628280-25-050332 |
| Q2 2025Quarterly · 2025-06-30 | Geography | Americas Excluding United States | 2,667,000 | USD | 0001770787-25-000051 |
| Q2 2025Quarterly · 2025-06-30 | Geography | Asia Pacific Excluding China | 8,846,000 | USD | 0001770787-25-000051 |
| Q2 2025Quarterly · 2025-06-30 | Geography | China | 23,170,000 | USD | 0001770787-25-000051 |
| Q2 2025Quarterly · 2025-06-30 | Geography | EMEA | 34,734,000 | USD | 0001770787-25-000051 |
| Q2 2025Quarterly · 2025-06-30 | Geography | United States | 103,491,000 | USD | 0001770787-25-000051 |
| Q2 2025Quarterly · 2025-06-30 | Product | Licensing And Royalty Revenue | 27,751,000 | USD | 0001770787-25-000051 |
| Q2 2025Quarterly · 2025-06-30 | Product | Product And Service Revenue — Chromium Consumables | 85,788,000 | USD | 0001770787-25-000051 |
| Q2 2025Quarterly · 2025-06-30 | Product | Product And Service Revenue — Chromium Instruments | 5,727,000 | USD | 0001770787-25-000051 |
| Q2 2025Quarterly · 2025-06-30 | Product | Product And Service Revenue — Services | 8,475,000 | USD | 0001770787-25-000051 |
| Q2 2025Quarterly · 2025-06-30 | Product | Product And Service Revenue — Spatial Consumables | 36,397,000 | USD | 0001770787-25-000051 |
| Q2 2025Quarterly · 2025-06-30 | Product | Product And Service Revenue — Spatial Instruments | 8,770,000 | USD | 0001770787-25-000051 |
| Q1 2025Quarterly · 2025-03-31 | Geography | Americas Excluding United States | 3,752,000 | USD | 0001628280-26-032388 |
| Q1 2025Quarterly · 2025-03-31 | Geography | Asia Pacific Excluding China | 15,535,000 | USD | 0001628280-26-032388 |
| Q1 2025Quarterly · 2025-03-31 | Geography | China | 16,883,000 | USD | 0001628280-26-032388 |
| Q1 2025Quarterly · 2025-03-31 | Geography | EMEA | 31,895,000 | USD | 0001628280-26-032388 |
| Q1 2025Quarterly · 2025-03-31 | Geography | United States | 86,818,000 | USD | 0001628280-26-032388 |
| Q1 2025Quarterly · 2025-03-31 | Product | Licensing And Royalty Revenue | 17,060,000 | USD | 0001628280-26-032388 |
| Q1 2025Quarterly · 2025-03-31 | Product | Product And Service Revenue — Chromium Consumables | 84,109,000 | USD | 0001628280-26-032388 |
| Q1 2025Quarterly · 2025-03-31 | Product | Product And Service Revenue — Chromium Instruments | 5,913,000 | USD | 0001628280-26-032388 |
| Q1 2025Quarterly · 2025-03-31 | Product | Product And Service Revenue — Services | 7,652,000 | USD | 0001628280-26-032388 |
| Q1 2025Quarterly · 2025-03-31 | Product | Product And Service Revenue — Spatial Consumables | 31,247,000 | USD | 0001628280-26-032388 |
| Q1 2025Quarterly · 2025-03-31 | Product | Product And Service Revenue — Spatial Instruments | 8,902,000 | USD | 0001628280-26-032388 |
| Q4 2024Quarterly · 2024-12-31 | Geography | Americas Excluding United States | 2,936,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Geography | Asia Pacific Excluding China | 13,363,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Geography | China | 14,608,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Geography | EMEA | 49,828,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Geography | United States | 84,286,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Chromium Consumables | 97,737,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Chromium Instruments | 10,929,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Services | 7,136,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Spatial Consumables | 35,794,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Spatial Instruments | 13,425,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-12-31 | Geography | Americas Excluding United States | 13,447,000 | USD | 0001628280-26-007822 |
| FY 2024Yearly · 2024-12-31 | Geography | Asia Pacific Excluding China | 45,958,000 | USD | 0001628280-26-007822 |
| FY 2024Yearly · 2024-12-31 | Geography | China | 57,300,000 | USD | 0001628280-26-007822 |
| FY 2024Yearly · 2024-12-31 | Geography | EMEA | 159,762,000 | USD | 0001628280-26-007822 |
| FY 2024Yearly · 2024-12-31 | Geography | United States | 334,318,000 | USD | 0001628280-26-007822 |
| FY 2024Yearly · 2024-12-31 | Product | Licensing And Royalty Revenue | 321,000 | USD | 0001628280-26-007822 |
| FY 2024Yearly · 2024-12-31 | Product | Product And Service Revenue — Services | 24,317,000 | USD | 0001628280-26-007822 |
| FY 2024Yearly · 2024-12-31 | Product | Product And Service Revenue — Single Cell Consumables | 372,308,000 | USD | 0001628280-26-007822 |
| FY 2024Yearly · 2024-12-31 | Product | Product And Service Revenue — Single Cell Instruments | 35,212,000 | USD | 0001628280-26-007822 |
| FY 2024Yearly · 2024-12-31 | Product | Product And Service Revenue — Spatial Consumables | 121,124,000 | USD | 0001628280-26-007822 |
| FY 2024Yearly · 2024-12-31 | Product | Product And Service Revenue — Spatial Instruments | 57,503,000 | USD | 0001628280-26-007822 |
| Q3 2024Quarterly · 2024-09-30 | Geography | Americas Excluding United States | 3,099,000 | USD | 0001628280-25-050332 |
| Q3 2024Quarterly · 2024-09-30 | Geography | Asia Pacific Excluding China | 10,951,000 | USD | 0001628280-25-050332 |
| Q3 2024Quarterly · 2024-09-30 | Geography | China | 15,030,000 | USD | 0001628280-25-050332 |
| Q3 2024Quarterly · 2024-09-30 | Geography | EMEA | 37,851,000 | USD | 0001628280-25-050332 |
| Q3 2024Quarterly · 2024-09-30 | Geography | United States | 84,723,000 | USD | 0001628280-25-050332 |
| Q3 2024Quarterly · 2024-09-30 | Product | Licensing And Royalty Revenue | 95,000 | USD | 0001628280-25-050332 |
| Q3 2024Quarterly · 2024-09-30 | Product | Product And Service Revenue — Chromium Consumables | 96,536,000 | USD | 0001628280-25-050332 |
| Q3 2024Quarterly · 2024-09-30 | Product | Product And Service Revenue — Chromium Instruments | 7,641,000 | USD | 0001628280-25-050332 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.